Board of Scientific Counselors, Coordinating Center for Infectious Diseases (CCID), 53278-53279 [E9-24937]

Download as PDF 53278 Federal Register / Vol. 74, No. 199 / Friday, October 16, 2009 / Notices Contact Person: Karen Lechter, PhD, Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 3128, MSC 7759, Bethesda, MD 20892. 301–496– 0726. lechterk@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel, RFA–OD– 09–008 BRDG–SPAN and RFA–OD–09–009 Catalyst ARRA Review Panel 9. Date: November 17, 2009. Time: 8:30 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: Hilton Washington/Rockville, 1750 Rockville Pike, Rockville, MD 20852. Contact Person: Aftab A. Ansari, PhD, Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 4108, MSC 7814, Bethesda, MD 20892. 301–594– 6376. ansaria@csr.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; 93.333, Clinical Research,93.306, 93.333, 93.337, 93.393–93.396, 93.837–93.844, 93.846–93.878, 93.892, 93.893, National Institutes of Health, HHS) Dated: October 9, 2009. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. E9–24976 Filed 10–15–09; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Center for Scientific Review; Amended Notice of Meeting jlentini on DSKJ8SOYB1PROD with NOTICES Notice is hereby given of a change in the meeting of the Center for Scientific Review Special Emphasis Panel, November 5, 2009, 8 a.m. to November 6, 2009, 5:00 PM, Hotel Nikko San Francisco, 222 Mason Street, San Francisco, CA, 94102 which was published in the Federal Register on October 2, 2009, 74 FR 50975–50977. The meeting title has been changed to ‘‘Fellowship: Cell Biology and Development’’. The meeting is closed to the public. Dated: October 9, 2009. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. E9–24975 Filed 10–15–09; 8:45 am] BILLING CODE 4140–01–P VerDate Nov<24>2008 16:37 Oct 15, 2009 Jkt 220001 DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Neurological Disorders and Stroke; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Neurological Disorders and Stroke Special Emphasis Panel; NINDS T–32 Review. Date: December 1–2, 2009. Time: 8 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: Argonaut Hotel, 495 Jefferson Street, San Francisco, CA 94109. Contact Person: Phillip F. Wiethorn, Scientific Review Administrator, DHHS/NIH/ NINDS/DER/SRB, 6001 Executive Boulevard; MSC 9529, Neuroscience Center; Room 3203, Bethesda, MD 20892–9529, (301) 496–5388, wiethorp@ninds.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.853, Clinical Research Related to Neurological Disorders; 93.854, Biological Basis Research in the Neurosciences, National Institutes of Health, HHS) Dated: October 9, 2009. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. E9–24972 Filed 10–15–09; 8:45 am] provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Child Health and Human Development Special Emphasis Panel, IERDA. Date: November 13, 2009. Time: 10 a.m. to 4 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6100 Executive Boulevard, Room 5B01, Rockville, MD 20852. (Telephone Conference Call). Contact Person: Michele C. HindiAlexander, PhD, Division of Scientific Review, National Institutes of Health, Eunice Kennedy Shriver National Institute of Child Health and Human Development, 6100 Executive Boulevard, Rm. 5B01, Bethesda, MD 20892. (301) 435–8382. hindialm@mail.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.864, Population Research; 93.865, Research for Mothers and Children; 93.929, Center for Medical Rehabilitation Research; 93.209, Contraception and Infertility Loan Repayment Program, National Institutes of Health, HHS) Dated: October 9, 2009. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. E9–24966 Filed 10–15–09; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Board of Scientific Counselors, Coordinating Center for Infectious Diseases (CCID) BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Eunice Kennedy Shriver National Institute of Child Health & Human Development; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the PO 00000 Frm 00066 Fmt 4703 Sfmt 4703 In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC), announces the following meeting of the aforementioned committee: Times and Dates: 9 a.m.–5 p.m., November 4, 2009 (Working Groups). 8:30 a.m.–3:30 p.m., November 5, 2009 (Full Board). Place: Emory Conference Center, 1615 Clifton Road, NE., Atlanta, Georgia 30329, Telephone: (404) 712–6000. Status: Open to the public, limited only by the space available. Purpose: The Board of Scientific Counselors, CCID, provides advice and E:\FR\FM\16OCN1.SGM 16OCN1 Federal Register / Vol. 74, No. 199 / Friday, October 16, 2009 / Notices guidance to the Director, CDC, and Director, CCID, in the following areas: program goals and objectives; strategies; program organization and resources for infectious disease prevention and control; and program priorities. Matters To Be Discussed: Agenda items will include: 1. Working Groups: Environmental Microbiology, research to guide public health practice (National Center for Preparedness, Detection, and Control of Infectious Diseases; National Center for Immunization and Respiratory Diseases (NCIRD); and National Center for Zoonotic, Vector-Borne, and Enteric Diseases (NCZVED) Morning Session); Strategic Plan (National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention); Review of Funding provided through the American Recovery and Reinvestment Act of 2009 (ARRA) for immunization programs funded under Section 317 of the Public Health Service Act (NCIRD Afternoon Session); Strategic Framework and Program Reviews and Strategies (NCZVED Afternoon Session). 2. Full Board: H1N1 discussion; announcements and introductions; and follow-up on actions recommended by the board. Agenda items are subject to change as priorities dictate. Written comments are welcome and should be received by the contact person listed below prior to the opening of the meeting. Contact Person For More Information: Harriette Lynch, Office of the Director, CCID, CDC, Mailstop E–77, 1600 Clifton Road, NE., Atlanta, Georgia 30333, e-mail: hlynch@cdc.gov, Telephone (404) 498–2726. The Director, Management Analysis and Services office has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Dated: October 8, 2009. Andre Tyler, Acting Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. E9–24937 Filed 10–15–09; 8:45 am] DEPARTMENT OF HEALTH AND HUMAN SERVICES DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Food and Drug Administration [Docket No. FDA–2009–N–0664] Health Resources and Services Administration; CDC/HRSA Advisory Committee on HIV and STD Prevention and Treatment In accordance with section l0(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), CDC and HRSA announce the following meeting of the aforementioned committee: Times and Dates: 8 a.m.–5:30 p.m., November 2, 2009. 8 a.m.–3 p.m., November 3, 2009. Place: Hyatt Regency Bethesda, 7400 Wisconsin Avenue (One Bethesda Metro Center), Bethesda, Maryland 20814, Telephone: (301) 657–1234. Status: Open to the public, limited only by the space available. The meeting room will accommodate approximately 100 people. Purpose: This Committee is charged with advising the Director, CDC, and the Administrator, HRSA, regarding activities related to prevention and control of HIV/ AIDS and other STDs, the support of health care services to persons living with HIV/ AIDS, and education of health professionals and the public about HIV/AIDS and other STDs. Matters to be Discussed: Agenda items include issues pertaining to: (1) HIV/STD/ HCV Prevention, Treatment and Care in Federally Qualified Health Centers; (2) Biomedical Approaches to HIV Prevention— Pre-Exposure Prophylaxis; (3) Federal Adolescent Sexual Health Education Initiatives; and (4) Role of Surveillance in Informing CDC and HRSA Activities. Agenda items are subject to change as priorities dictate. Contact Person for More Information: Margie Scott-Cseh, Coordinating Center for Infectious Diseases, Strategic Business Unit, CDC, 1600 Clifton Road, NE., Mailstop E–07, Atlanta, Georgia 30333, Telephone: (404) 639–8317. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register Notices pertaining to announcements of meetings and other committee management activities, for both the CDC and the Agency for Toxic Substances and Disease Registry. Dated: October 8, 2009. Andre Tyler, Acting Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. E9–24934 Filed 10–15–09; 8:45 am] BILLING CODE 4163–18–P jlentini on DSKJ8SOYB1PROD with NOTICES BILLING CODE 4163–18–P VerDate Nov<24>2008 16:37 Oct 15, 2009 Jkt 220001 53279 PO 00000 Frm 00067 Fmt 4703 Sfmt 4703 Request for Nominations for Voting Members on Public Advisory Panels or Committees AGENCY: Food and Drug Administration, HHS. ACTION: Notice. SUMMARY: The Food and Drug Administration (FDA) is requesting nominations for voting members to serve on the Device Good Manufacturing Practice Advisory Committee, certain device panels of the Medical Devices Advisory Committee, the National Mammography Quality Assurance Advisory Committee, and the Technical Electronic Products Radiation Safety Standards Committee in the Center for Devices and Radiological Health. Nominations will be accepted for current vacancies and those that will or may occur through August 31, 2010. FDA has a special interest in ensuring that women, minority groups, and individuals with disabilities are adequately represented on advisory committees and, therefore, encourages nominations of qualified candidates from these groups. DATES: Because scheduled vacancies occur on various dates throughout each year, no cutoff date is established for the receipt of nominations. However, when possible, nominations should be received at least 6 months before the date of scheduled vacancies for each year, as indicated in this notice. ADDRESSES: All nomination for membership should be sent electronically to CV@OC.FDA.GOV, or by mail to Advisory Committee Oversight & Management Staff (HF–4), 5600 Fishers Lane, rm. 14C03, Rockville, MD 20857. Information about becoming a member on a FDA advisory committee can also be obtained by visiting FDA’s Web site at https:// www.fda.gov/AdvisoryCommittees/ default.htm. FOR FURTHER INFORMATION CONTACT: For specific Committee questions, contact the following persons listed in table 1 of this document. E:\FR\FM\16OCN1.SGM 16OCN1

Agencies

[Federal Register Volume 74, Number 199 (Friday, October 16, 2009)]
[Notices]
[Pages 53278-53279]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-24937]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Board of Scientific Counselors, Coordinating Center for 
Infectious Diseases (CCID)

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC), announces the following meeting of the aforementioned 
committee:

    Times and Dates:
    9 a.m.-5 p.m., November 4, 2009 (Working Groups).
    8:30 a.m.-3:30 p.m., November 5, 2009 (Full Board).
    Place: Emory Conference Center, 1615 Clifton Road, NE., Atlanta, 
Georgia 30329, Telephone: (404) 712-6000.
    Status: Open to the public, limited only by the space available.
    Purpose: The Board of Scientific Counselors, CCID, provides 
advice and

[[Page 53279]]

guidance to the Director, CDC, and Director, CCID, in the following 
areas: program goals and objectives; strategies; program 
organization and resources for infectious disease prevention and 
control; and program priorities.
    Matters To Be Discussed: Agenda items will include:
    1. Working Groups: Environmental Microbiology, research to guide 
public health practice (National Center for Preparedness, Detection, 
and Control of Infectious Diseases; National Center for Immunization 
and Respiratory Diseases (NCIRD); and National Center for Zoonotic, 
Vector-Borne, and Enteric Diseases (NCZVED) Morning Session); 
Strategic Plan (National Center for HIV/AIDS, Viral Hepatitis, STD, 
and TB Prevention); Review of Funding provided through the American 
Recovery and Reinvestment Act of 2009 (ARRA) for immunization 
programs funded under Section 317 of the Public Health Service Act 
(NCIRD Afternoon Session); Strategic Framework and Program Reviews 
and Strategies (NCZVED Afternoon Session).
    2. Full Board:
    H1N1 discussion; announcements and introductions; and follow-up 
on actions recommended by the board.
    Agenda items are subject to change as priorities dictate.
    Written comments are welcome and should be received by the 
contact person listed below prior to the opening of the meeting.
    Contact Person For More Information: Harriette Lynch, Office of 
the Director, CCID, CDC, Mailstop E-77, 1600 Clifton Road, NE., 
Atlanta, Georgia 30333, e-mail: hlynch@cdc.gov, Telephone (404) 498-
2726.
    The Director, Management Analysis and Services office has been 
delegated the authority to sign Federal Register notices pertaining 
to announcements of meetings and other committee management 
activities, for both the Centers for Disease Control and Prevention 
and the Agency for Toxic Substances and Disease Registry.

    Dated: October 8, 2009.
Andre Tyler,
Acting Director, Management Analysis and Services Office, Centers for 
Disease Control and Prevention.
[FR Doc. E9-24937 Filed 10-15-09; 8:45 am]
BILLING CODE 4163-18-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.